VISHEE(SH:688580) Xin Lang Cai Jing·2025-10-17 06:57Company Overview - Weisi Medical, established on January 10, 2001, is located in Nanjing, Jiangsu Province, and was listed on July 21, 2020. The company focuses on the research, development, production, and sales of rehabilitation medical devices, particularly in areas such as pelvic and postpartum rehabilitation, neurological rehabilitation, and mental rehabilitation [1]. Business Performance - As of October 17, Weisi Medical's stock price decreased by 5.08%, trading at 46.73 CNY per share, with a total market capitalization of 4.475 billion CNY. The trading volume was 70.9737 million CNY, and the turnover rate was 1.55% [1]. - The revenue composition of Weisi Medical includes: magnetic stimulation products (39.44%), consumables and accessories (19.42%), electrophysiological products (19.18%), laser radiofrequency products (10.26%), electrical stimulation products (8.42%), and others (3.28%) [1]. Fund Holdings - According to data, Beixin Ruifeng Fund holds a significant position in Weisi Medical through its health lifestyle theme flexible allocation fund (001056), which maintained 90,000 shares in the second quarter, accounting for 4.68% of the fund's net value, ranking as the seventh largest holding [2]. - The fund has a total scale of 90.1431 million CNY and has achieved a year-to-date return of 29.83%, ranking 2886 out of 8160 in its category [2]. Fund Management - The fund manager of Beixin Ruifeng's health lifestyle theme flexible allocation fund is Pang Wenjie, who has been in the position for 5 years and 140 days. The fund's total asset size is 18.4 million CNY, with the best return during his tenure being 44.46% and the worst being -40.05% [3].